aod9604 clinical trial results BioWorld Understanding AOD 9604: The Science

It was found through preliminary research that treatment with AOD9604 over the course of 14 days in obese mice led to decreased body weight and body fat and was shown to increase the activity of the beta(3)-adrenergic receptors in the fat cells to the same level as those in lean mice

One of its greatest advantage is the quick effect and self-injection method

Both methods can effectively raise your vitamin B12 levels, but they work differently

Insert the needle at a 45-90 degree angle depending on how much subcutaneous fat exists at the site

This body of research is part of why Tesamorelin is frequently used as a comparison anchor when researchers evaluate other peptides effects on fat metabolism